Literature DB >> 577157

Experimental blood vascular and lymphatic occlusion in the rabbit ear and the effect of benzopyrones.

J R Casley-Smith, L Clodius, M Földi.   

Abstract

The effects of lymphostasis and its treatment by a mixture of benzopyrones were studied in the pinnae of rabbit ears. The blood and lymph circulations to the dorsal surfaces of the ears were largely interrupted by excising a portion of skin down to the perichondrium from one edge to the other. The untreated ears became very lymphoedematous, became necrotic and tell off between 7 and 34 days after the operation. The treated ears were much less lymphoedematous, both to the naked eye and by electron microscopy. Owing to the ubiquity of action of the benzopyrones, the phagocytic capacity of the macrophages is enhanced, removing the accumulating protein, the metabolic products and thus the oedematous fluid. This improves the tissue oxygenation, encouraging lymphatic and vascular regeneration and, to a lesser degree, recanalisation. Also, the red blood cells are protected against lactacidotic rigidification and they and the macrophages are given an increased chance of survival in the remaining stagnant areas by the enhancement of glucose up-take and transport. Upon these factors rests the ability of the tissue to survive. The fact that the ears in the treated groups did not fall off, gives a real indication of the potentiality of the benzopyrones.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 577157

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  6 in total

1.  Lymphoedema of the rabbit ear following partial and complete lymphatic blockade; its effects on fibrotic development, enzyme types and their activity levels.

Authors:  N B Piller; L Clodius
Journal:  Br J Exp Pathol       Date:  1978-06

2.  Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation.

Authors:  Peter Baluk; Tuomas Tammela; Erin Ator; Natalya Lyubynska; Marc G Achen; Daniel J Hicklin; Michael Jeltsch; Tatiana V Petrova; Bronislaw Pytowski; Steven A Stacker; Seppo Ylä-Herttuala; David G Jackson; Kari Alitalo; Donald M McDonald
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

3.  Rhesus monkey is a new model of secondary lymphedema in the upper limb.

Authors:  Guojun Wu; Hao Xu; Wenhong Zhou; Xianshun Yuan; Zhe Yang; Qing Yang; Feng Ding; Zhigang Meng; Weili Liang; Chong Geng; Ling Gao; Xingsong Tian
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.

Authors:  Young-Sup Yoon; Toshinori Murayama; Edwin Gravereaux; Tengiz Tkebuchava; Marcy Silver; Cynthia Curry; Andrea Wecker; Rudolf Kirchmair; Chun Song Hu; Marianne Kearney; Alan Ashare; David G Jackson; Hajime Kubo; Jeffrey M Isner; Douglas W Losordo
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

5.  Modification of a rodent hindlimb model of secondary lymphedema: surgical radicality versus radiotherapeutic ablation.

Authors:  Hyung Sub Park; In Mok Jung; Geum Hee Choi; Soli Hahn; Young Sun Yoo; Taeseung Lee
Journal:  Biomed Res Int       Date:  2013-11-14       Impact factor: 3.411

Review 6.  Emerging Roles of Lymphatic Vasculature in Immunity.

Authors:  Ki-Wook Kim; Joo-Hye Song
Journal:  Immune Netw       Date:  2017-02-23       Impact factor: 6.303

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.